Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

Base Biotech Raises “Tens of Millions of Dollars” in A1 Round for Base Editing
Everest Approved to Launch Antibiotic in China for Intra-Abdominal Infections
Mabwell Starts Trials of mAb to Regulate Iron Homeostasis In Vivo
Simcere to Test TNRF2 mAb in Combination with MSD’s Keytruda for Solid Tumors
Everest’s In-licensed Kidney Drug Meets Endpoints in Phase III Trial
ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China